首页 > 最新文献

American journal of human genetics最新文献

英文 中文
Competition in human genetic technologies: The current US legal landscape 人类基因技术的竞争:当前美国法律格局
IF 9.8 1区 生物学 Q1 GENETICS & HEREDITY Pub Date : 2026-01-21 DOI: 10.1016/j.ajhg.2025.12.012
Abdulai I. Rashid, Nicole A. Rincon, Nathan Rihani, Jennifer K. Wagner
{"title":"Competition in human genetic technologies: The current US legal landscape","authors":"Abdulai I. Rashid, Nicole A. Rincon, Nathan Rihani, Jennifer K. Wagner","doi":"10.1016/j.ajhg.2025.12.012","DOIUrl":"https://doi.org/10.1016/j.ajhg.2025.12.012","url":null,"abstract":"","PeriodicalId":7659,"journal":{"name":"American journal of human genetics","volume":"1 1","pages":""},"PeriodicalIF":9.8,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146014534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A gene-specific variance-control approach corrects polygenicity-driven inflation observed in transcriptome-wide association studies 基因特异性方差控制方法纠正了转录组全关联研究中观察到的多基因驱动的膨胀
IF 9.8 1区 生物学 Q1 GENETICS & HEREDITY Pub Date : 2026-01-20 DOI: 10.1016/j.ajhg.2025.12.014
Yanyu Liang, Festus Nyasimi, Hae Kyung Im
{"title":"A gene-specific variance-control approach corrects polygenicity-driven inflation observed in transcriptome-wide association studies","authors":"Yanyu Liang, Festus Nyasimi, Hae Kyung Im","doi":"10.1016/j.ajhg.2025.12.014","DOIUrl":"https://doi.org/10.1016/j.ajhg.2025.12.014","url":null,"abstract":"","PeriodicalId":7659,"journal":{"name":"American journal of human genetics","volume":"63 1","pages":""},"PeriodicalIF":9.8,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146014536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bi-allelic variants in neuronal adhesion molecule astrotactin 1 gene ASTN1 cause diverse neurodevelopmental disorders. 神经元粘附分子星形胶质蛋白1基因ASTN1的双等位基因变异导致多种神经发育障碍。
IF 9.8 1区 生物学 Q1 GENETICS & HEREDITY Pub Date : 2026-01-15 DOI: 10.1016/j.ajhg.2025.12.011
Jesse M Levine,Daniel G Calame,Riccardo Sangermano,Haowei Du,Ahmed Saad,Jasmin Lisfeld,Tatjana Bierhals,Jonas Denecke,Eyyup Uctepe,Merve Yoldas Celik,Ahmet Yesilyurt,Hilal Yildiz Er,Elif Yilmaz Gulec,Aziza Mushiba,Naif Almontashiri,Pawel Gawlinski,Wojciech Wiszniewski,Ender Karaca,Lama Alabdi,Davut Pehlivan,Dana Marafi,Maha S Zaki,Fowzan S Alkuraya,Joseph G Gleeson,Shalini N Jhangiani,Richard A Gibbs,Jennifer E Posey,Kinga M Bujakowska,James R Lupski
ASTN1 encodes astrotactin 1, a neuronal-glial ligand in the developing brain that promotes neuronal migration along radial glia in brain structures with laminar organization, such as the cerebral cortex, hippocampus, and cerebellum. In mouse models, disruption of Astn1 results in neuronal migration deficits, a mild reduction in cerebellar volume, and balance and coordination deficits. In humans, bi-allelic ASTN1 variants have been identified in nine individuals with neurodevelopmental disorders (NDDs) with or without brain malformations. ASTN1 additionally interacts with astrotactin 2 (ASTN2) to implement neuronal migration; ASTN2 deletions associate with NDDs with reduced penetrance. Here, we describe eighteen individuals with NDDs from twelve unrelated families with bi-allelic, ultra-rare, predicted damaging variants in ASTN1 and one individual with heterozygous variants in both ASTN1 and ASTN2. We expand the clinical phenotypic descriptions of ASTN1-related NDDs, which range from mild to profound developmental delay or intellectual disability and can be associated with autism, attention-deficient hyperactivity disorder (ADHD), and epilepsy. Other recurrent abnormalities include dysmorphic facial features, hypotonia, spasticity, and ataxia. Additionally, we add to the neuroradiographic phenotype of this condition, which can be normal, mildly dysmorphic (a thin corpus callosum and cerebellar dysgenesis), or severely dysmorphic (polymicrogyria and lissencephaly). Remarkably, three genetic models of multilocus pathogenic variation (MPV), including tri-allelic, double heterozygous, and double homozygous due to distributive absence of heterozygosity (AOH), were observed. This ASTN1 allelic series characterizes the consequences of perturbations in radial-glia-guided neuronal migration in humans, the phenotypic spectrum of ASTN1-related NDDs, and the contribution of MPV to the genetic basis of NDDs.
ASTN1编码星形胶质蛋白1,星形胶质蛋白1是发育中的大脑中的一种神经元-胶质配体,可促进神经元沿具有层状组织的大脑结构(如大脑皮层、海马和小脑)中的径向胶质迁移。在小鼠模型中,Astn1的破坏导致神经元迁移缺陷,小脑体积轻度减少,以及平衡和协调缺陷。在人类中,已在9例伴有或不伴有脑畸形的神经发育障碍(ndd)患者中发现了双等位基因ASTN1变异。ASTN1还与星形胶质蛋白2 (ASTN2)相互作用,实现神经元迁移;ASTN2缺失与外显率降低的ndd相关。在这里,我们描述了来自12个不相关家族的18名ndd患者,他们在ASTN1中具有双等位基因,超罕见,预测的破坏性变异体,并且在ASTN1和ASTN2中具有杂合变异体。我们扩大了与astn1相关的ndd的临床表型描述,其范围从轻度到重度发育迟缓或智力残疾,并可能与自闭症、注意力缺陷多动障碍(ADHD)和癫痫有关。其他复发性异常包括面部畸形、张力低下、痉挛和共济失调。此外,我们增加了这种疾病的神经放射学表型,它可以是正常的,轻度畸形(薄胼胝体和小脑发育不良),或严重畸形(多小回畸形和无脑畸形)。值得注意的是,多位点致病变异(MPV)有三种遗传模式,包括三等位基因、双杂合子和双纯合子(由于分布性杂合子缺失(AOH))。该ASTN1等位基因系列表征了人类径向胶质细胞引导的神经元迁移中扰动的后果,ASTN1相关ndd的表型谱,以及MPV对ndd遗传基础的贡献。
{"title":"Bi-allelic variants in neuronal adhesion molecule astrotactin 1 gene ASTN1 cause diverse neurodevelopmental disorders.","authors":"Jesse M Levine,Daniel G Calame,Riccardo Sangermano,Haowei Du,Ahmed Saad,Jasmin Lisfeld,Tatjana Bierhals,Jonas Denecke,Eyyup Uctepe,Merve Yoldas Celik,Ahmet Yesilyurt,Hilal Yildiz Er,Elif Yilmaz Gulec,Aziza Mushiba,Naif Almontashiri,Pawel Gawlinski,Wojciech Wiszniewski,Ender Karaca,Lama Alabdi,Davut Pehlivan,Dana Marafi,Maha S Zaki,Fowzan S Alkuraya,Joseph G Gleeson,Shalini N Jhangiani,Richard A Gibbs,Jennifer E Posey,Kinga M Bujakowska,James R Lupski","doi":"10.1016/j.ajhg.2025.12.011","DOIUrl":"https://doi.org/10.1016/j.ajhg.2025.12.011","url":null,"abstract":"ASTN1 encodes astrotactin 1, a neuronal-glial ligand in the developing brain that promotes neuronal migration along radial glia in brain structures with laminar organization, such as the cerebral cortex, hippocampus, and cerebellum. In mouse models, disruption of Astn1 results in neuronal migration deficits, a mild reduction in cerebellar volume, and balance and coordination deficits. In humans, bi-allelic ASTN1 variants have been identified in nine individuals with neurodevelopmental disorders (NDDs) with or without brain malformations. ASTN1 additionally interacts with astrotactin 2 (ASTN2) to implement neuronal migration; ASTN2 deletions associate with NDDs with reduced penetrance. Here, we describe eighteen individuals with NDDs from twelve unrelated families with bi-allelic, ultra-rare, predicted damaging variants in ASTN1 and one individual with heterozygous variants in both ASTN1 and ASTN2. We expand the clinical phenotypic descriptions of ASTN1-related NDDs, which range from mild to profound developmental delay or intellectual disability and can be associated with autism, attention-deficient hyperactivity disorder (ADHD), and epilepsy. Other recurrent abnormalities include dysmorphic facial features, hypotonia, spasticity, and ataxia. Additionally, we add to the neuroradiographic phenotype of this condition, which can be normal, mildly dysmorphic (a thin corpus callosum and cerebellar dysgenesis), or severely dysmorphic (polymicrogyria and lissencephaly). Remarkably, three genetic models of multilocus pathogenic variation (MPV), including tri-allelic, double heterozygous, and double homozygous due to distributive absence of heterozygosity (AOH), were observed. This ASTN1 allelic series characterizes the consequences of perturbations in radial-glia-guided neuronal migration in humans, the phenotypic spectrum of ASTN1-related NDDs, and the contribution of MPV to the genetic basis of NDDs.","PeriodicalId":7659,"journal":{"name":"American journal of human genetics","volume":"36 1","pages":""},"PeriodicalIF":9.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145986470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic regulation of fatty acid content in adipose tissue 脂肪组织中脂肪酸含量的遗传调控
IF 9.8 1区 生物学 Q1 GENETICS & HEREDITY Pub Date : 2026-01-14 DOI: 10.1016/j.ajhg.2025.12.008
Xinyu Yan, Amy L. Roberts, Julia S. El-Sayed Moustafa, Sergio Villicaña, Maryam Al-Hilal, Max Tomlinson, Cristina Menni, Thomas A.B. Sanders, Maxim B. Freidin, Jordana T. Bell, Kerrin S. Small
{"title":"Genetic regulation of fatty acid content in adipose tissue","authors":"Xinyu Yan, Amy L. Roberts, Julia S. El-Sayed Moustafa, Sergio Villicaña, Maryam Al-Hilal, Max Tomlinson, Cristina Menni, Thomas A.B. Sanders, Maxim B. Freidin, Jordana T. Bell, Kerrin S. Small","doi":"10.1016/j.ajhg.2025.12.008","DOIUrl":"https://doi.org/10.1016/j.ajhg.2025.12.008","url":null,"abstract":"","PeriodicalId":7659,"journal":{"name":"American journal of human genetics","volume":"46 1","pages":""},"PeriodicalIF":9.8,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145962520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular genotype-phenotype correlation in ACTB- and ACTG1-related non-muscle actinopathies ACTB-和actg1相关的非肌肉放线素病的分子基因型-表型相关性
IF 9.8 1区 生物学 Q1 GENETICS & HEREDITY Pub Date : 2026-01-12 DOI: 10.1016/j.ajhg.2025.12.007
Nataliya Di Donato, NMA Consortium, Andrew Thom, Andreas Rump, Johannes N. Greve, Juan Cadiñanos, Salvatore Calabro, Sara Cathey, Brian Chung, Heidi Cope, Maria Costales, Sara Cuvertino, Philine Dinkel, Kalliopi Erripi, Andrew E. Fry, Livia Garavelli, Sabine Hoffjan, Wibke G. Janzarik, Insa Kreimer, Grazia Mancini, Purificacion Marin-Reina, Andrea Meinhardt, Indra Niehaus, Daniela Pilz, Ivana Ricca, Fernando Santos Simarro, Evelin Schrock, Anja Marquardt, Manuel H. Taft, Kamer Tezcan, Sofia Thunström, Judith Verhagen, Alain Verloes, Bernd Wollnik, Peter Krawitz, Tzung-Chien Hsieh, Michael Seifert, Michael Heide, Catherine B. Lawrence, Neil A. Roberts, Dietmar J. Manstein, Adrian S. Woolf, Siddharth Banka
Recent advances in Mendelian genomics reveal the importance of variant-level characterization of allelic disorders. Non-muscle actin isoforms, encoded by the genes ACTB and ACTG1, are the most abundant intracellular proteins, but historically, they are often regarded as merely being “housekeeping” molecules. Here, we illuminate the extraordinary clinical heterogeneity and complex pathobiology of genetic non-muscle actinopathies. To do this, we combine human genomics studies with molecular biology. Strikingly, variants in ACTB and ACTG1 isoforms generate at least eight distinct clinical disorders. A subset of disease-associated missense variants causes dysregulated actin polymerization-depolymerization and neuronal migration defects. In contrast, nonsense, frameshift, and missense variants enhancing protein degradation cause milder phenotypes or are benign. These results emphasize the essential functional aspects of the non-muscle actin isoforms. Critically, they additionally constitute a template for the personalized genetic variant-level-driven management of the pleiotropic allelic single-gene disorders.
孟德尔基因组学的最新进展揭示了等位基因疾病变异水平表征的重要性。由ACTB和ACTG1基因编码的非肌肉肌动蛋白亚型是最丰富的细胞内蛋白,但从历史上看,它们通常被认为仅仅是“管家”分子。在这里,我们阐明了非凡的临床异质性和复杂的病理生物学的遗传性非肌肉放线素病。为此,我们将人类基因组学研究与分子生物学结合起来。引人注目的是,ACTB和ACTG1亚型的变异产生至少8种不同的临床疾病。一组疾病相关的错义变异导致肌动蛋白聚合-解聚失调和神经元迁移缺陷。相比之下,无意义,移码和错义变异增强蛋白质降解引起温和的表型或是良性的。这些结果强调了非肌肉肌动蛋白异构体的基本功能方面。至关重要的是,它们还构成了个性化遗传变异水平驱动的多效等位基因单基因疾病管理的模板。
{"title":"Molecular genotype-phenotype correlation in ACTB- and ACTG1-related non-muscle actinopathies","authors":"Nataliya Di Donato, NMA Consortium, Andrew Thom, Andreas Rump, Johannes N. Greve, Juan Cadiñanos, Salvatore Calabro, Sara Cathey, Brian Chung, Heidi Cope, Maria Costales, Sara Cuvertino, Philine Dinkel, Kalliopi Erripi, Andrew E. Fry, Livia Garavelli, Sabine Hoffjan, Wibke G. Janzarik, Insa Kreimer, Grazia Mancini, Purificacion Marin-Reina, Andrea Meinhardt, Indra Niehaus, Daniela Pilz, Ivana Ricca, Fernando Santos Simarro, Evelin Schrock, Anja Marquardt, Manuel H. Taft, Kamer Tezcan, Sofia Thunström, Judith Verhagen, Alain Verloes, Bernd Wollnik, Peter Krawitz, Tzung-Chien Hsieh, Michael Seifert, Michael Heide, Catherine B. Lawrence, Neil A. Roberts, Dietmar J. Manstein, Adrian S. Woolf, Siddharth Banka","doi":"10.1016/j.ajhg.2025.12.007","DOIUrl":"https://doi.org/10.1016/j.ajhg.2025.12.007","url":null,"abstract":"Recent advances in Mendelian genomics reveal the importance of variant-level characterization of allelic disorders. Non-muscle actin isoforms, encoded by the genes <ce:italic>ACTB</ce:italic> and <ce:italic>ACTG1</ce:italic>, are the most abundant intracellular proteins, but historically, they are often regarded as merely being “housekeeping” molecules. Here, we illuminate the extraordinary clinical heterogeneity and complex pathobiology of genetic non-muscle actinopathies. To do this, we combine human genomics studies with molecular biology. Strikingly, variants in <ce:italic>ACTB</ce:italic> and <ce:italic>ACTG1</ce:italic> isoforms generate at least eight distinct clinical disorders. A subset of disease-associated missense variants causes dysregulated actin polymerization-depolymerization and neuronal migration defects. In contrast, nonsense, frameshift, and missense variants enhancing protein degradation cause milder phenotypes or are benign. These results emphasize the essential functional aspects of the non-muscle actin isoforms. Critically, they additionally constitute a template for the personalized genetic variant-level-driven management of the pleiotropic allelic single-gene disorders.","PeriodicalId":7659,"journal":{"name":"American journal of human genetics","volume":"259 1","pages":""},"PeriodicalIF":9.8,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145957372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional analysis of NPR2 variants supports the therapeutic rationale for CNP in short stature. NPR2变异的功能分析支持矮个子CNP的治疗原理。
IF 9.8 1区 生物学 Q1 GENETICS & HEREDITY Pub Date : 2026-01-08 DOI: 10.1016/j.ajhg.2025.12.006
Raehoon Jeong,Sergio Covarrubias,Devanshi Shanghavi,Donald Ruhrmund,Karol Estrada,Dejie Zhou,Nofar Marom,Christopher R Bauer,Steven Froelich
Human height is a complex trait regulated by genetic and environmental factors. Several components of chondrocyte proliferation and differentiation regulatory pathways are implicated in short-stature disorders; one such component is natriuretic peptide receptor 2 (NPR2), the receptor for C-type natriuretic peptide. We developed a high-throughput GFP reporter assay to evaluate the functional impact of NPR2 missense variants on receptor activity, which was utilized alongside a commercially available CatchPoint assay, and previously published data. Measurements from these sources were integrated and annotated, providing an "activity score" for each variant, based on reduced or increased receptor activity. Unlike variant effect prediction tools that assign scores from benign to pathogenic, our method enabled us to distinguish loss-of-function and gain-of-function variants, categorizing 245 NPR2 missense variants, including 47 loss-of-function, 34 partial loss-of-function, and 14 gain-of-function variants, across the functional domains of NPR2. Activity scores showed a near-linear association with standing height (Pearson's correlation R2 = 0.438, p = 5.8 × 10-10), with the effects additive and apparent across polygenic backgrounds. Moreover, phenome-wide association analysis demonstrated that NPR2 activity was significantly associated only with height and height-associated traits, suggesting that modulating NPR2 activity may modulate height only. To summarize, the relationship between NPR2 activity and height resembles a dimmer switch, whereby subtle variations in activity cause subtle variations in height. We demonstrate the therapeutic potential of modulating NPR2 activity in short-stature conditions, owing to both its strong association with height and its lack of association with traits unrelated to height.
人类身高是一个复杂的性状,受遗传和环境因素的影响。软骨细胞增殖和分化调控途径的几个组成部分与矮小障碍有关;其中一种成分是利钠肽受体2 (NPR2),即c型利钠肽的受体。我们开发了一种高通量GFP报告基因检测方法来评估NPR2错义变异体对受体活性的功能影响,该方法与市售的CatchPoint检测方法和先前发表的数据一起使用。对这些来源的测量结果进行整合和注释,根据受体活性的降低或增加,为每个变体提供“活性评分”。与将评分从良性到致病性的变异效应预测工具不同,我们的方法使我们能够区分功能丧失和功能获得变异,对245个NPR2错义变异进行分类,包括47个功能丧失,34个部分功能丧失和14个功能获得变异,横跨NPR2的功能域。活动得分与站立高度呈近似线性相关(Pearson相关系数R2 = 0.438, p = 5.8 × 10-10),且在多基因背景下具有可加性和显著性。此外,全表型关联分析表明,NPR2活性仅与身高和身高相关性状显著相关,表明调节NPR2活性可能仅调节身高。总而言之,NPR2活动与身高之间的关系类似于一个调光开关,因此活动的细微变化会导致身高的细微变化。我们证明了调节NPR2活性在矮个子条件下的治疗潜力,因为它与身高有很强的相关性,而与身高无关的特征缺乏相关性。
{"title":"Functional analysis of NPR2 variants supports the therapeutic rationale for CNP in short stature.","authors":"Raehoon Jeong,Sergio Covarrubias,Devanshi Shanghavi,Donald Ruhrmund,Karol Estrada,Dejie Zhou,Nofar Marom,Christopher R Bauer,Steven Froelich","doi":"10.1016/j.ajhg.2025.12.006","DOIUrl":"https://doi.org/10.1016/j.ajhg.2025.12.006","url":null,"abstract":"Human height is a complex trait regulated by genetic and environmental factors. Several components of chondrocyte proliferation and differentiation regulatory pathways are implicated in short-stature disorders; one such component is natriuretic peptide receptor 2 (NPR2), the receptor for C-type natriuretic peptide. We developed a high-throughput GFP reporter assay to evaluate the functional impact of NPR2 missense variants on receptor activity, which was utilized alongside a commercially available CatchPoint assay, and previously published data. Measurements from these sources were integrated and annotated, providing an \"activity score\" for each variant, based on reduced or increased receptor activity. Unlike variant effect prediction tools that assign scores from benign to pathogenic, our method enabled us to distinguish loss-of-function and gain-of-function variants, categorizing 245 NPR2 missense variants, including 47 loss-of-function, 34 partial loss-of-function, and 14 gain-of-function variants, across the functional domains of NPR2. Activity scores showed a near-linear association with standing height (Pearson's correlation R2 = 0.438, p = 5.8 × 10-10), with the effects additive and apparent across polygenic backgrounds. Moreover, phenome-wide association analysis demonstrated that NPR2 activity was significantly associated only with height and height-associated traits, suggesting that modulating NPR2 activity may modulate height only. To summarize, the relationship between NPR2 activity and height resembles a dimmer switch, whereby subtle variations in activity cause subtle variations in height. We demonstrate the therapeutic potential of modulating NPR2 activity in short-stature conditions, owing to both its strong association with height and its lack of association with traits unrelated to height.","PeriodicalId":7659,"journal":{"name":"American journal of human genetics","volume":"10 1","pages":"117-132"},"PeriodicalIF":9.8,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145937730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
De novo variants in KDM2A cause a syndromic neurodevelopmental disorder. KDM2A的新生变异导致综合征性神经发育障碍。
IF 8.1 1区 生物学 Q1 GENETICS & HEREDITY Pub Date : 2026-01-08 Epub Date: 2025-12-29 DOI: 10.1016/j.ajhg.2025.12.004
Eric N Anderson, Stephan Drukewitz, Sukhleen Kour, Anuradha V Chimata, Deepa S Rajan, Senta Schönnagel, Karen L Stals, Deirdre Donnelly, Siobhan O'Sullivan, John F Mantovani, Tiong Y Tan, Zornitza Stark, Pia Zacher, Nicolas Chatron, Pauline Monin, Severine Drunat, Yoann Vial, Xenia Latypova, Jonathan Levy, Alain Verloes, Jennefer N Carter, Devon E Bonner, Suma P Shankar, Jonathan A Bernstein, Julie S Cohen, Anne Comi, Deanna Alexis Carere, Lisa M Dyer, Sureni V Mullegama, Pedro A Sanchez-Lara, Katheryn Grand, Hyung-Goo Kim, Afif Ben-Mahmoud, Sidney M Gospe, Rebecca S Belles, Gary Bellus, Klaske D Lichtenbelt, Renske Oegema, Anita Rauch, Ivan Ivanovski, Frederic Tran Mau-Them, Aurore Garde, Rachel Rabin, John Pappas, Annette E Bley, Janna Bredow, Timo Wagner, Eva Decker, Carsten Bergmann, Louis Domenach, Henri Margot, Johannes R Lemke, Rami Abou Jamra, Julia Hentschel, Heather Mefford, Amit Singh, Udai Bhan Pandey, Konrad Platzer

Germline variants that disrupt components of the epigenetic machinery cause syndromic neurodevelopmental disorders. Using exome and genome sequencing, we identified de novo variants in KDM2A, a lysine demethylase crucial for embryonic development, in 18 individuals with developmental delays and/or intellectual disabilities. The severity ranged from learning disabilities to severe intellectual disability. Other core symptoms included feeding difficulties; growth issues, such as intrauterine growth restriction, short stature, and microcephaly; and recurrent facial features, such as epicanthic folds, upslanted palpebral fissures, thin vermillion of the lips, and low-set ears. Expression of human disease-causing KDM2A variants in a Drosophila melanogaster model led to neural degeneration, motor defects, and reduced lifespan. Interestingly, pathogenic variants in KDM2A affected physiological attributes, including subcellular distribution, expression, and stability in human cells. Genetic epistasis experiments indicated that KDM2A variants act via a dual mechanism-loss of nuclear function for some variants tested and additional cytoplasmic gain-of-function toxicity for c.704C>T (p.Pro235Leu), as eliminating endogenous Drosophila Kdm2 did not produce noticeable neurodevelopmental phenotypes. Data from enzymatic-methylation sequencing support the suggested gene-disease association by showing aberrant methylome profiles in affected individuals' peripheral blood. Combining our genetic, phenotypic, and functional findings, we establish de novo variants in KDM2A as causative for a syndromic neurodevelopmental disorder.

破坏表观遗传机制成分的种系变异引起综合征性神经发育障碍。通过外显子组和基因组测序,我们在18名发育迟缓和/或智力残疾的个体中发现了KDM2A(一种对胚胎发育至关重要的赖氨酸去甲基化酶)的新生变异。其严重程度从学习障碍到严重智力障碍不等。其他核心症状包括进食困难;生长问题,如宫内生长受限、身材矮小和小头畸形;以及反复出现的面部特征,如上睑褶皱、上斜睑裂、朱红色的薄嘴唇和低耳。在黑胃果蝇模型中表达人类致病的KDM2A变异导致神经变性、运动缺陷和寿命缩短。有趣的是,KDM2A的致病变异影响了生理属性,包括亚细胞分布、表达和人类细胞的稳定性。遗传上位性实验表明,KDM2A变异通过双重机制起作用——一些被测试的变异的细胞核功能丧失和c.704C>T (p.p pro235leu)的细胞质功能获得毒性,因为消除内源性的果蝇Kdm2不会产生明显的神经发育表型。来自酶甲基化测序的数据通过在受影响个体的外周血中显示异常的甲基组谱来支持所建议的基因与疾病的关联。结合我们的遗传、表型和功能发现,我们确定KDM2A的新生变异是综合征性神经发育障碍的病因。
{"title":"De novo variants in KDM2A cause a syndromic neurodevelopmental disorder.","authors":"Eric N Anderson, Stephan Drukewitz, Sukhleen Kour, Anuradha V Chimata, Deepa S Rajan, Senta Schönnagel, Karen L Stals, Deirdre Donnelly, Siobhan O'Sullivan, John F Mantovani, Tiong Y Tan, Zornitza Stark, Pia Zacher, Nicolas Chatron, Pauline Monin, Severine Drunat, Yoann Vial, Xenia Latypova, Jonathan Levy, Alain Verloes, Jennefer N Carter, Devon E Bonner, Suma P Shankar, Jonathan A Bernstein, Julie S Cohen, Anne Comi, Deanna Alexis Carere, Lisa M Dyer, Sureni V Mullegama, Pedro A Sanchez-Lara, Katheryn Grand, Hyung-Goo Kim, Afif Ben-Mahmoud, Sidney M Gospe, Rebecca S Belles, Gary Bellus, Klaske D Lichtenbelt, Renske Oegema, Anita Rauch, Ivan Ivanovski, Frederic Tran Mau-Them, Aurore Garde, Rachel Rabin, John Pappas, Annette E Bley, Janna Bredow, Timo Wagner, Eva Decker, Carsten Bergmann, Louis Domenach, Henri Margot, Johannes R Lemke, Rami Abou Jamra, Julia Hentschel, Heather Mefford, Amit Singh, Udai Bhan Pandey, Konrad Platzer","doi":"10.1016/j.ajhg.2025.12.004","DOIUrl":"10.1016/j.ajhg.2025.12.004","url":null,"abstract":"<p><p>Germline variants that disrupt components of the epigenetic machinery cause syndromic neurodevelopmental disorders. Using exome and genome sequencing, we identified de novo variants in KDM2A, a lysine demethylase crucial for embryonic development, in 18 individuals with developmental delays and/or intellectual disabilities. The severity ranged from learning disabilities to severe intellectual disability. Other core symptoms included feeding difficulties; growth issues, such as intrauterine growth restriction, short stature, and microcephaly; and recurrent facial features, such as epicanthic folds, upslanted palpebral fissures, thin vermillion of the lips, and low-set ears. Expression of human disease-causing KDM2A variants in a Drosophila melanogaster model led to neural degeneration, motor defects, and reduced lifespan. Interestingly, pathogenic variants in KDM2A affected physiological attributes, including subcellular distribution, expression, and stability in human cells. Genetic epistasis experiments indicated that KDM2A variants act via a dual mechanism-loss of nuclear function for some variants tested and additional cytoplasmic gain-of-function toxicity for c.704C>T (p.Pro235Leu), as eliminating endogenous Drosophila Kdm2 did not produce noticeable neurodevelopmental phenotypes. Data from enzymatic-methylation sequencing support the suggested gene-disease association by showing aberrant methylome profiles in affected individuals' peripheral blood. Combining our genetic, phenotypic, and functional findings, we establish de novo variants in KDM2A as causative for a syndromic neurodevelopmental disorder.</p>","PeriodicalId":7659,"journal":{"name":"American journal of human genetics","volume":" ","pages":"100-116"},"PeriodicalIF":8.1,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12824617/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145861599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LiMA: Robust inference of molecular mediation from summary statistics. 从汇总统计得出的分子中介的稳健推断。
IF 9.8 1区 生物学 Q1 GENETICS & HEREDITY Pub Date : 2026-01-08 DOI: 10.1016/j.ajhg.2025.12.005
Kaido Lepik,Chiara Auwerx,Marie C Sadler,Adriaan van der Graaf,Sven Erik Ojavee,Zoltán Kutalik
Understanding the molecular mechanisms mediating the causal effects of epidemiological risk factors on complex traits can advance targeted disease interventions. Statistical mediation analysis facilitates this by disentangling direct and indirect causal effects. Current approaches to causal mediation leverage Mendelian randomization, using summary statistics from the exposure, mediator, and outcome studies that estimate the genetic effects of instruments. However, differences in study sample sizes (measurement errors) lead to substantial biases and poorly controlled type I error rates for these methods, which become especially pronounced when simultaneously estimating the mediation proportion of numerous mediators. To address these limitations, we introduce Likelihood-based Mediation Analysis (LiMA), which estimates molecular mediation more accurately and robustly by jointly modeling the variability in all estimates involved. Through extensive simulation studies and benchmarking, we demonstrate that our approach achieves several-fold lower bias and improved control for type I error than state-of-the-art methods. Applying our method to real data highlighted several plausible metabolites-such as glutamate and carnitine-as well as proteins mediating the causal effects of obesity-related risk factors on cardiometabolic outcomes. These findings underscore the potential of our framework to reveal promising molecular pathways underlying complex diseases. By accommodating the variability inherent to summary statistics of varying precision, LiMA enables robust mediation analyses across large sets of mediators.
了解介导流行病学危险因素对复杂性状因果影响的分子机制可以推进有针对性的疾病干预。统计中介分析通过理清直接和间接的因果关系促进了这一点。目前的因果中介方法利用孟德尔随机化,使用来自暴露、中介和结果研究的汇总统计数据来估计仪器的遗传效应。然而,研究样本量的差异(测量误差)导致这些方法存在大量偏差和控制不佳的I型错误率,在同时估计众多介质的中介比例时,这一点尤为明显。为了解决这些限制,我们引入了基于似然的中介分析(LiMA),它通过联合建模所有相关估计的可变性来更准确和稳健地估计分子中介。通过广泛的模拟研究和基准测试,我们证明我们的方法比最先进的方法实现了几倍的低偏差和改进的I型误差控制。将我们的方法应用于真实数据,突出了几种可能的代谢物,如谷氨酸和肉毒碱,以及介导肥胖相关风险因素对心脏代谢结果的因果影响的蛋白质。这些发现强调了我们的框架在揭示复杂疾病背后有希望的分子途径方面的潜力。通过适应不同精度的汇总统计所固有的可变性,LiMA支持跨大型中介集进行稳健的中介分析。
{"title":"LiMA: Robust inference of molecular mediation from summary statistics.","authors":"Kaido Lepik,Chiara Auwerx,Marie C Sadler,Adriaan van der Graaf,Sven Erik Ojavee,Zoltán Kutalik","doi":"10.1016/j.ajhg.2025.12.005","DOIUrl":"https://doi.org/10.1016/j.ajhg.2025.12.005","url":null,"abstract":"Understanding the molecular mechanisms mediating the causal effects of epidemiological risk factors on complex traits can advance targeted disease interventions. Statistical mediation analysis facilitates this by disentangling direct and indirect causal effects. Current approaches to causal mediation leverage Mendelian randomization, using summary statistics from the exposure, mediator, and outcome studies that estimate the genetic effects of instruments. However, differences in study sample sizes (measurement errors) lead to substantial biases and poorly controlled type I error rates for these methods, which become especially pronounced when simultaneously estimating the mediation proportion of numerous mediators. To address these limitations, we introduce Likelihood-based Mediation Analysis (LiMA), which estimates molecular mediation more accurately and robustly by jointly modeling the variability in all estimates involved. Through extensive simulation studies and benchmarking, we demonstrate that our approach achieves several-fold lower bias and improved control for type I error than state-of-the-art methods. Applying our method to real data highlighted several plausible metabolites-such as glutamate and carnitine-as well as proteins mediating the causal effects of obesity-related risk factors on cardiometabolic outcomes. These findings underscore the potential of our framework to reveal promising molecular pathways underlying complex diseases. By accommodating the variability inherent to summary statistics of varying precision, LiMA enables robust mediation analyses across large sets of mediators.","PeriodicalId":7659,"journal":{"name":"American journal of human genetics","volume":"244 1","pages":"202-220"},"PeriodicalIF":9.8,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145937731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
This month in The Journal 本月的《华尔街日报》
IF 9.8 1区 生物学 Q1 GENETICS & HEREDITY Pub Date : 2026-01-08 DOI: 10.1016/j.ajhg.2025.12.009
Paul W. Hook, Alyson B. Barnes
{"title":"This month in The Journal","authors":"Paul W. Hook, Alyson B. Barnes","doi":"10.1016/j.ajhg.2025.12.009","DOIUrl":"https://doi.org/10.1016/j.ajhg.2025.12.009","url":null,"abstract":"","PeriodicalId":7659,"journal":{"name":"American journal of human genetics","volume":"187 1","pages":""},"PeriodicalIF":9.8,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145957373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The dawn of interventional genetics. 介入遗传学的曙光。
IF 8.1 1区 生物学 Q1 GENETICS & HEREDITY Pub Date : 2026-01-08 DOI: 10.1016/j.ajhg.2025.12.010
Kiran Musunuru
{"title":"The dawn of interventional genetics.","authors":"Kiran Musunuru","doi":"10.1016/j.ajhg.2025.12.010","DOIUrl":"10.1016/j.ajhg.2025.12.010","url":null,"abstract":"","PeriodicalId":7659,"journal":{"name":"American journal of human genetics","volume":"113 1","pages":"1-2"},"PeriodicalIF":8.1,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12824614/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American journal of human genetics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1